Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Centre hospitalier de l'Université de Montréal (CHUM)
Psyence Australia Pty Ltd
Daiichi Sankyo
Daiichi Sankyo
Mayo Clinic
Tempus AI
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Xencor, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jules Bordet Institute
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
Jiangsu HengRui Medicine Co., Ltd.
Seagen Inc.
University of Iowa
National Cancer Institute (NCI)
National Cancer Institute (NCI)